• 1. An artificial blood vessel implanted three-dimensional microsystem for modeling transvascular migration of tumor cells?
  Xue-Ying Wang,Ying Pei,Min Xie,Zi-He Jin,Ya-Shi Xiao,Yang Wang,Li-Na Zhang,Yan Li,Wei-Hua Huang Lab Chip, 2015,15, 1178-1187
• 2. An air-stable organometallic polymer containing titanafluorene moieties obtained by the Sonogashira–Hagihara cross-coupling polycondensation?
  Alvin Tanudjaja,Shinsuke Inagi,Fusao Kitamura,Toshikazu Takata,Ikuyoshi Tomita Dalton Trans., 2021,50, 3037-3043
• 3. An antimonate pyrochlore (H1.23Sr0.45SbO3.48) for photocatalytic oxidation of benzene: effective oxygen usage and excellent activity?
  Jing Chen,Yu Shao,Danzhen Li J. Mater. Chem. A, 2017,5, 937-941
• 4. Acentric and chiral heterometallic inorganic–organic hybrid frameworks mediated by alkali or alkaline earth ions: synthesis and NLO properties
  Huabin Zhang,Shaowu Du CrystEngComm, 2014,16, 4059-4068
• 5. An apparatus for testing water by measurement of its electrical conductivity
  Analyst, 1912,37, 538-543

Introduction to 1-Propanone, 2,2-dimethyl-1-(3-pyridinyl)- (CAS No: 65321-29-1)

1-Propanone, 2,2-dimethyl-1-(3-pyridinyl)-, identified by its Chemical Abstracts Service (CAS) number 65321-29-1, is a specialized organic compound that has garnered significant attention in the field of pharmaceutical and chemical research. This compound belongs to the class of pyridine derivatives, featuring a unique structural framework that combines a ketone group with a pyridine moiety. The presence of these functional groups imparts distinct chemical properties, making it a valuable intermediate in synthetic chemistry and a potential candidate for various biological applications.

The molecular structure of 1-Propanone, 2,2-dimethyl-1-(3-pyridinyl)- consists of a central propanone backbone substituted with two methyl groups at the 2-position and a 3-pyridinyl group at the 1-position. This arrangement creates a molecule with high steric hindrance due to the bulky methyl groups, which can influence its reactivity and interactions with biological targets. The pyridine ring, on the other hand, is known for its ability to form hydrogen bonds and coordinate with metal ions, making it a versatile scaffold in drug design.

In recent years, there has been growing interest in exploring the pharmacological potential of pyridine derivatives, particularly those incorporating heterocyclic structures. The compound 1-Propanone, 2,2-dimethyl-1-(3-pyridinyl)- has been studied for its potential role in developing novel therapeutic agents. Its unique structural features suggest that it may interact with biological macromolecules in ways that could be exploited for therapeutic purposes. For instance, the pyridine moiety could serve as a binding site for enzymes or receptors, while the ketone group could participate in covalent modifications or redox reactions.

One of the most compelling aspects of 1-Propanone, 2,2-dimethyl-1-(3-pyridinyl)- is its synthetic versatility. The compound can be used as a building block in multi-step organic synthesis, allowing chemists to construct more complex molecules with tailored properties. Researchers have leveraged this compound to develop new synthetic pathways for other pharmacologically relevant molecules. Additionally, its stability under various reaction conditions makes it a reliable reagent in laboratory settings.

The biological activity of 1-Propanone, 2,2-dimethyl-1-(3-pyridinyl)- has been investigated in several preclinical studies. Initial findings suggest that it may exhibit inhibitory effects on certain enzymes and receptors involved in inflammatory and neurological pathways. These preliminary results have prompted further research into its potential as a lead compound for drug development. The compound's ability to modulate biological processes could make it useful in treating conditions such as inflammation, pain, and neurodegenerative disorders.

Advances in computational chemistry have also played a crucial role in understanding the behavior of 1-Propanone, 2,2-dimethyl-1-(3-pyridinyl)-. Molecular modeling studies have provided insights into its binding interactions with target proteins and its metabolic pathways. These computational approaches have helped researchers optimize its structure for improved efficacy and reduced toxicity. By integrating experimental data with computational predictions, scientists can design more effective derivatives of this compound.

The synthesis of 1-Propanone, 2,2-dimethyl-1-(3-pyridinyl)- involves multi-step organic reactions that require careful optimization to achieve high yields and purity. Common synthetic routes include condensation reactions between ketones and pyridine derivatives, followed by functional group modifications. The use of advanced catalytic systems has further improved the efficiency of these synthetic processes. For instance, transition metal-catalyzed cross-coupling reactions have enabled the introduction of complex substituents into the molecular framework with high precision.

In conclusion,1-Propanone, 2,2-dimethyl-1-(3-pyridinyl)- (CAS No: 65321-29-1) is a promising compound with significant potential in pharmaceutical research. Its unique structural features and biological activity make it an attractive candidate for further investigation. As research continues to uncover new applications for this molecule,it is likely to play an important role in the development of innovative therapeutic strategies.

• 54-36-4(Metyrapone)
• 1570-48-5(3-Propionylpyridine)
• 24966-13-0(3-cyclopropanecarbonylpyridine)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)